# Safety and Efficacy of BC LisPram

> **NCT04972175** · PHASE1 · UNKNOWN · sponsor: **Michael Tsoukas** · enrollment: 16 (estimated)

## Conditions studied

- Type1 Diabetes Mellitus

## Interventions

- **DRUG:** 50-Hour Intervention - Rapid Insulin lispro
- **DRUG:** 50-Hour Intervention - BC LisPram

## Key facts

- **NCT ID:** NCT04972175
- **Lead sponsor:** Michael Tsoukas
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-28
- **Primary completion:** 2022-06
- **Final completion:** 2022-06
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2022-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04972175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04972175, "Safety and Efficacy of BC LisPram". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04972175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*